| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |